Precigen, Inc. (PGEN)
NASDAQ · Manufacturing · Pharmaceutical preparations
PGEN price, last 12 months
Key stats
- Previous close
- $7.70
- Open
- $7.76
- Day range
- $7.63 – $8.27
- 52-week range
- $2.99 – $8.27
- Volume
- 6M
- Avg volume (20 days)
- 4.2M
- Market cap
- $2.8B
Performance
Technicals and fundamentals
About Precigen, Inc.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $2.8B